No Injections Needed: The First GLP-1 Obesity Pill Has Arrived in the U.S.
Novo Nordisk has begun U.S. sales of an oral version of Wegovy, giving patients a once-daily alternative to weekly shots — and opening a new pricing and access battle in…







